Fresenius Hid Cardiac Risks Of Dialysis Treatment, Suit Says

Law360, New York (February 11, 2013, 5:57 PM EST) -- A man who claims a dialysis treatment made by Fresenius Medical Care North America sent him into cardiac arrest sued the company in New Jersey on Friday, saying it deceived consumers and regulators as to the treatment’s safety.

Plaintiff William C. Jones claims that Fresenius concealed its knowledge of the defects and risks of Naturalyte liquid acid concentrate and Granuflo dry acid concentrate from patients, the medical community and the U.S. Food and Drug Administration, resulting in injuries to himself and other dialysis patients.

“These representations...
To view the full article, register now.